Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea
· Delayed Price · Currency is KRW 27,150
-850 (-3.04%)
Apr 16, 2025, 3:30 PM KST
-20.61% (1Y)
| Market Cap | 1.42T |
| Revenue (ttm) | 138.94B |
| Net Income (ttm) | -1.80B |
| Shares Out | 50.77M |
| EPS (ttm) | -35.59 |
| PE Ratio | n/a |
| Forward PE | 178.57 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 192,915 |
| Average Volume | 501,062 |
| Open | 28,000 |
| Previous Close | 28,000 |
| Day's Range | 26,900 - 28,250 |
| 52-Week Range | 24,200 - 52,000 |
| Beta | 0.81 |
| RSI | 43.12 |
| Earnings Date | May 13, 2025 |